Adamas Pharma, LLC

United States of America


 
Total IP 49
Total IP Rank # 28,108
IP Activity Score 1.8/5.0    10
IP Activity Rank # 89,756
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

35 6
5 1
1 0
1
 
Last Patent 2022 - Composition and method for treat...
First Patent 2005 - Method and composition for admin...
Last Trademark 2021 - PICTURE MORE TIME
First Trademark 2015 - GOCOVRI

Industry (Nice Classification)

Latest Inventions, Goods, Services

2021 Invention Composition and method for treating neurological disease. Disclosed are compositions comprising ...
Invention Amantadine compositions, preparations thereof, and methods of use. Provided herein are oral phar...
G/S Providing a website featuring information in the field of treatment and management of dyskinesia ...
2020 Invention Methods of administering amantadine. Methods of nighttime administration of amantadine to reduce ...
2019 Invention Method of administering amantadine prior to a sleep period. Methods of nighttime administration o...
Invention Amantadine compositions and preparations thereof. Provided herein are oral pharmaceutical composi...
Invention Methods of using amantadine compositions. Provided herein are oral pharmaceutical compositions co...
Invention Composition for administering an nmda receptor antagonist to a subject. The invention provides e...
2018 Invention Amantadine compositions, preparations thereof, and methods of use. Provided herein are oral pharm...
G/S Providing computerized solution-based technologies for the purpose of patient support services to...
Invention Amantadine compositions and methods of use. Methods of nighttime administration of amantadine to...
G/S patient assistance program that provides medical drugs to help patients with insufficient resourc...
2017 G/S Pharmaceuticals for the treatment of disorders of the central nervous system, namely, Parkinson's...
Invention Compositions for the treatment of cns-related conditions. The invention provides methods for tre...
G/S Pharmaceuticals for the treatment of nervous system disorders.
G/S Oral pharmaceuticals for treatment of neurological conditions
2015 Invention Methods of administering amantadine compositions. Methods of administration of amantadine to imp...
Invention Oral adamantine in the treatment of gait disorders in multiple sclerosis patients. Described here...
G/S Pharmaceuticals for the treatment of nervous system disorders
Invention Composition and method for treating neurological disease. Disclosed are compositions comprising a...
2014 Invention Composition and method for treating neurological disease. A method of administering amantadine is...
2013 Invention Method for administering an nmda receptor antagonist to a subject. Compositions and methods for a...
2012 Invention Compositions for the treatment of cns-related conditions. The invention provides compositions com...
Invention Method for administering an nmda receptor antagonist to a subject. The invention provides methods...
Invention Methods for the treatment of cns-related conditions. The invention provides methods for administe...
Invention Composition for administering an nmda receptor antagonist to a subject. The invention provides co...